Addition of Metformin to Concurrent Chemoradiation in Patients With Locally Advanced Non–Small Cell Lung Cancer

Overview of attention for article published in JAMA Oncology, September 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

news: 7 news outlets
blogs: 1 blog

twitter: 84 tweeters

Citations

dimensions_citation: 25 Dimensions

Readers on

mendeley: 29 Mendeley

Summary News Blogs Twitter Dimensions citations

So far, Dimensions has found 25 publications that cite this research output.

25

The most recent citing publications are shown below. View all 25 publications that cite this research output on Dimensions.

Drug Repurposing in Non-Small Cell Lung Carcinoma: Old Solutions for New Problems

Article in Current Oncology (January 2023)

Metabolic targeting, immunotherapy and radiation in locally advanced non-small cell lung cancer: Where do we go from here?

Article in Frontiers in Oncology (December 2022)

Addition of metformin to non‐small‐cell lung cancer patients with or without diabetes

Article in Thoracic Cancer (November 2022)